Desktop Site
|
26 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,730.16
-609.28
-0.82 %
Corporate Announcement
Security Code
531739
Company
GENNEX LABORATORIES LTD.
Exchange Received Time
14/02/2024 17:27:49
Exchange Disseminated Time
14/02/2024 17:27:50
Time Taken
00:00:01
Results - Financial Results For Quarter And Nine Months Ended December 31, 2023 |
2/14/2024 5:27:50 PM
In just concluded meeting of Board of Directors, the Board approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statement for the Quarter and Nine months ended December 31, 2023 2.Limited Review Reports from the Statutory Auditors on unaudited (Standalone and Consolidated) Financial Statement for the Quarter and Nine months ended December 31, 2023 3. Acceptance of resignation of Mr. Tiruvarur Muralidharan Gopalakrishnan, Whole time Director of the Company 4. Appointment of Dr, S.CH. Dharma Rao, as Additional Director (Non-Executive - Non-Independent Director) of the Company. We hereby submit that the Board Meeting had commenced at 4.00 PM and concluded at 5.00 PM. This intimation is also uploaded on the Company website: www.gennexlab.com We request you to take the above information on record and acknowledge the receipt.
Attachment
<< Back
Recently Viewed